Home » Bayer Buys Sample-Prep System From Hamilton to Develop IVD Platform

Bayer Buys Sample-Prep System From Hamilton to Develop IVD Platform

Jul 31, 2006
NEW YORK (GenomeWeb News) - Bayer Healthcare today said it will buy a customized Microlab STARlet sample-preparation system from Hamilton Company as part of its plan to develop a new platform for performing molecular diagnostics.
 
The two companies will work together to customize the platform to meet the requirements of Bayer’s quantitative PCR technology.
 
Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Silencing for Preeclampsia

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

Settlement Expected in Duke Case

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

This Week in PNAS

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Something Different

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

What's Popular?

In Clinical Sequencing

  1. Hospitals Build Case for Pathogen Sequencing to Track Resistance, Monitor Outbreaks

    Premium

  2. Adaptive Biotechnologies, U of Florida, Kings College London Collaborate on Diabetes Study

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.